Brief: Inozyme Pharma Q3 EPS USD -0.29
07/11/2023 13:31
Nov 7 (Reuters) - Inozyme Pharma Q3 EPS USD -0.29. * Q3 net income USD -16.6 million
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin